1. Anthropic IPO is crowding the calendar, Moynihan says
Bank of America Chief Executive Brian Moynihan said in a television interview on November 16, 2026, that the Anthropic IPO is crowding smaller companies out of the new-issue market, with some of their public offerings likely to be delayed until as late as 2027. The artificial intelligence developer is seeking to raise up to $64.4 billion, which would rank among the largest initial public offerings on record.
The remarks came from the head of one of the largest banks in the United States, an institution with a direct view of how companies and investors are positioning around the deal. Moynihan's assessment was his own reading of market conditions and was not presented as the result of a formal study. Even so, it offers a rare on-the-record description of how a single transaction is reshaping the plans of companies that have nothing to do with artificial intelligence.
During the same appearance, Moynihan also addressed artificial intelligence more broadly and spoke about his own succession plans at the bank. The comments about the new-issue market drew the most attention because of their timing, arriving as the Anthropic transaction approaches its final stages.
2. Why is the Anthropic IPO delaying other offerings?
A deal of up to $64.4 billion absorbs a large share of the money and attention that investors have available for new listings, leaving less room for smaller companies that would otherwise come to market at the same time. That is the dynamic Moynihan described when he said the offering is crowding out other issuers.
The mechanics are familiar to anyone who has watched a busy new-issue calendar. Institutional investors such as mutual funds, pension managers and hedge funds set aside a finite amount of capital for initial public offerings. They also have a finite number of analysts and portfolio managers to study prospectuses, attend management presentations and decide how many shares to request. When one transaction is large enough to demand a significant portion of both, other deals compete for what is left.
For a smaller company, launching into that environment carries obvious risk. An offering that receives only partial attention from the biggest buyers may attract weaker demand, which can translate into a lower price or a smaller raise than the company and its advisers had planned. Management teams and their bankers generally prefer to wait for a clearer window than to accept those terms.
Timing compounds the problem. Offerings tend to slow toward the end of the calendar year, when trading desks thin out and investors become more reluctant to take on new positions. A company that steps aside in mid-November to avoid a very large deal has few workable dates left before the holidays. Waiting, in practice, means waiting until the following year, which is consistent with Moynihan's view that some offerings could be pushed as far as 2027.
3. The scale of the deal
Size is what sets this transaction apart. With targeted proceeds of up to $64.4 billion, the Anthropic offering is expected to be one of the largest initial public offerings in history. Most companies that go public raise a small fraction of that amount, and even a deal of a few billion dollars is usually considered a major event for the market.
The scale reflects Anthropic's position as one of the leading commercial developers of frontier artificial intelligence, the term used for the most capable general-purpose models. Building and running those systems requires heavy spending on computing capacity and research staff, and public markets offer a deep pool of capital to fund it.
A listing of this magnitude also functions as a test of investor appetite for the artificial intelligence sector as a whole. Market participants appear to regard the offering as a major event in its own right, significant enough that other issuers are adjusting their schedules around it instead of competing with it directly. That behaviour is itself a signal of how much weight the market is assigning to the outcome.
4. What the delays mean for smaller issuers
Companies that postpone a listing do not simply pick up where they left off. A delay stretches the period during which a business must rely on private funding, existing cash or debt. It can require financial statements in the offering documents to be refreshed with newer results, and it leaves early investors and employees waiting longer for the liquidity that a public listing provides.
There is also a strategic cost. A company that planned to use a public listing to fund expansion, pay down borrowings or make acquisitions has to rework those plans around a later date. Conditions in the market could be better by then, or they could be worse, and there is no way to know in advance which it will be.
At the same time, the pattern Moynihan described is one of postponement, not cancellation. His comments suggest that the affected offerings are being rescheduled, with 2027 as the outer boundary, and not that the companies behind them have abandoned their plans. If that reading holds, the effect of the Anthropic transaction would be to shift new-issue activity from one period into another, producing a quieter stretch now and a potentially busier one later.
For investors, the consequence is a narrower set of choices in the near term. Those looking for exposure to newly listed companies will find the calendar dominated by a single name, with smaller and more varied offerings arriving only after that deal has been absorbed.
5. How an offering comes to market
Understanding why one deal can displace others requires a look at the steps every listing follows. A company first files a registration statement with the Securities and Exchange Commission, which reviews the disclosure and may ask for changes before the document is declared effective. Only then can shares be sold to the public.
With the filing in hand, management begins a period of investor meetings while the underwriting banks collect indications of interest, a process known as building the book. The final price is set once that demand is tallied, and shares begin trading shortly afterwards. Each stage depends on having investors' time and attention, and the last two depend on their capital as well.
Because those steps follow a fixed sequence, a company cannot easily compress its schedule to slip in ahead of a larger rival, nor can it pause halfway through without cost. The realistic choices are to launch alongside the bigger transaction and accept the competition for demand, or to hold back until the market has digested it. Moynihan's remarks indicate that a number of smaller issuers are choosing the second course.
The same logic applies in reverse once a very large deal is complete. Money that investors had reserved for the offering is either committed to it or released, analysts return to other prospectuses, and banks resume conversations with clients that had been waiting. How quickly that normalization happens depends in part on how the large deal is received, since a well-absorbed listing tends to encourage further issuance while a poorly received one can discourage it.
6. Why a bank chief's view carries weight
Large banks sit at the centre of the new-issue process. They advise companies on when to list, help set the price, and distribute shares to investors. Their executives hear from both sides of the market: from issuers deciding whether conditions are right, and from fund managers deciding where to commit capital.
That vantage point gives a statement from the chief executive of Bank of America more significance than a casual market observation. When Moynihan says smaller companies are being crowded out, he is describing conversations and decisions that his institution is positioned to observe directly.
It remains, however, a characterization and not a measurement. Moynihan did not present figures on how many offerings have been postponed or how much capital is involved, and the remarks should be read as an informed assessment of sentiment among issuers and investors. The practical test will be the new-issue calendar itself over the coming weeks and months.
7. What to watch next
Several developments will determine how the situation unfolds. The first is the Securities and Exchange Commission's review of Anthropic's registration statement, the document that sets out the company's finances, risks and the terms of the offering. Any extension of that review could delay the company's schedule, and with it the point at which other issuers feel able to return to the market.
The second is the timetable for the roadshow and pricing. The roadshow is the period in which a company's management presents its case to prospective investors, and pricing is the moment the final share price and deal size are fixed. Those dates define when the market's attention will be most heavily concentrated on the transaction, and when it will begin to free up.
Reports from the banks underwriting the deal are a third signal, since they indicate the strength of demand and how the shares are likely to be allocated. Commitments from strategic investors are the fourth. Large anchor orders can reduce the amount of stock that needs to be placed with the wider market, which in turn affects how much capacity remains for other deals.
Beyond the Anthropic transaction itself, the clearest indicator will be whether the smaller companies now on the sidelines begin to announce new launch dates. An early return would suggest the disruption was brief. A calendar that stays thin into the new year would bear out Moynihan's warning that the effects of one very large offering can extend well beyond its own debut.
